Janux Therapeutics JANX
NASDAQ JANX
$16.96 -0.32 (-1.85%)
At close: Oct 1, 2026 · 4:00 PM EDT

Janux Therapeutics (JANX) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Janux Therapeutics (JANX) recorded Net Equity Issued and Repurchased of $3.55 million in Q1 2026, up 293.5% from $901,000 a year earlier.

Analysis

Janux Therapeutics (JANX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

On a TTM basis, Janux Therapeutics' Net Equity Issued and Repurchased came in at $7.68 million as of Mar 31, 2026, up 85.7% year-over-year; for FY2021, it came in at $204.17 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Janux Therapeutics 1.06 Bn 1.06 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.55 Mn
Mar 31, 2025 901,000.00
Mar 31, 2024 1.66 Mn
Mar 31, 2023 1.58 Mn
Sep 30, 2021 -843,000.00
Dec 31, 2020 -4,000.00
API Access

Janux Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=JANX&period=max&api_key=YOUR_API_KEY